Compassionate Use (CU) of REGN5458 for Patients With Relapsed or Refractory Multiple Myeloma (MM)
Clinical trial NCT05164250 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05164250
- Sponsor
- Regeneron Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.